JP2025511929A5 - - Google Patents
Info
- Publication number
- JP2025511929A5 JP2025511929A5 JP2024559555A JP2024559555A JP2025511929A5 JP 2025511929 A5 JP2025511929 A5 JP 2025511929A5 JP 2024559555 A JP2024559555 A JP 2024559555A JP 2024559555 A JP2024559555 A JP 2024559555A JP 2025511929 A5 JP2025511929 A5 JP 2025511929A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- treating
- seq
- note
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263329039P | 2022-04-08 | 2022-04-08 | |
| US63/329,039 | 2022-04-08 | ||
| PCT/US2023/065047 WO2023196747A1 (en) | 2022-04-08 | 2023-03-28 | Long-acting granulocyte macrophage-colony stimulating factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511929A JP2025511929A (ja) | 2025-04-16 |
| JP2025511929A5 true JP2025511929A5 (https=) | 2026-04-06 |
Family
ID=88243563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559555A Pending JP2025511929A (ja) | 2022-04-08 | 2023-03-28 | 長時間作用型顆粒球マクロファージコロニー刺激因子 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250230210A1 (https=) |
| EP (1) | EP4504262A4 (https=) |
| JP (1) | JP2025511929A (https=) |
| KR (1) | KR20250004698A (https=) |
| CN (1) | CN119136831A (https=) |
| AU (1) | AU2023248440A1 (https=) |
| CA (1) | CA3247715A1 (https=) |
| TW (1) | TW202342089A (https=) |
| WO (1) | WO2023196747A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025247334A1 (en) * | 2024-05-30 | 2025-12-04 | Biosion Inc. | Recombinant fusion protein targeting siglec15 and gm-csfr |
| CN118909139A (zh) * | 2024-07-24 | 2024-11-08 | 广东壹加再生医学研究院有限公司 | 一种活化树突状细胞的分子、方法及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170002060A1 (en) * | 2014-01-08 | 2017-01-05 | Moderna Therapeutics, Inc. | Polynucleotides for the in vivo production of antibodies |
| HUE070957T2 (hu) * | 2017-02-16 | 2025-07-28 | Sonnet Biotherapeutics Inc | Albuminkötõ domén fúziós fehérjék |
| CA3070253A1 (en) * | 2017-07-19 | 2019-01-24 | Vib Vzw | Serum albumin binding agents |
| JP2023514972A (ja) * | 2020-02-12 | 2023-04-12 | ザ スクリプス リサーチ インスティテュート | 長時間作用型ｇｍ－ｃｓｆおよび使用方法 |
-
2023
- 2023-03-28 KR KR1020247035821A patent/KR20250004698A/ko active Pending
- 2023-03-28 AU AU2023248440A patent/AU2023248440A1/en active Pending
- 2023-03-28 JP JP2024559555A patent/JP2025511929A/ja active Pending
- 2023-03-28 CA CA3247715A patent/CA3247715A1/en active Pending
- 2023-03-28 CN CN202380037559.9A patent/CN119136831A/zh active Pending
- 2023-03-28 US US18/854,328 patent/US20250230210A1/en active Pending
- 2023-03-28 EP EP23785533.3A patent/EP4504262A4/en active Pending
- 2023-03-28 WO PCT/US2023/065047 patent/WO2023196747A1/en not_active Ceased
- 2023-04-07 TW TW112113134A patent/TW202342089A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260116940A1 (en) | Masked cytokine polypeptides | |
| KR102609197B1 (ko) | 인터류킨 15 단백질 복합체 및 그의 용도 | |
| US7226759B2 (en) | Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities | |
| JP2026012891A (ja) | 新規なマスクされたサイトカインおよびその使用方法 | |
| RU2369616C2 (ru) | Слитые белки il-7 | |
| JP6725532B2 (ja) | 多重特異性抗体によるサイトカインの非常に強力な中和およびその利用 | |
| JP7814759B2 (ja) | 二重特異性組換えタンパク質及びその使用 | |
| JP2025511929A5 (https=) | ||
| US20050036951A1 (en) | Methods of treating lung diseases | |
| JP2021527700A (ja) | ヘテロ二量体タンパク質及びその使用 | |
| CN108948207B (zh) | 一种人白细胞介素10-Fc融合蛋白及其编码基因与应用 | |
| WO2015103928A1 (zh) | Il-15异源二聚体蛋白及其用途 | |
| KR102910876B1 (ko) | 구획, 특히 cns로의 국소 전달을 위한 fc 변형 생물학적 제제 | |
| WO2022271716A2 (en) | Methods of using activin receptor type ii signaling inhibitors | |
| JP2024105648A5 (https=) | ||
| CN119790078A (zh) | 激动性白细胞介素15复合物及其用途 | |
| JP2025534020A (ja) | 治療的抗体薬物における抗体の突然変異方法の使用 | |
| JP7136690B2 (ja) | 免疫グロブリン融合タンパク質およびその使用 | |
| Mould | Using pharmacometrics in the development of therapeutic biological agents | |
| CA2977321C (en) | Ultra-potent neutralization of cytokines by multispecific antibodies and uses thereof | |
| Devereux et al. | Garanulocyte-macrophage colony-stimulating factor | |
| JP2024501659A5 (https=) | ||
| Kuerschner et al. | Interferon-γ receptor/immunoglobulin hybrid molecules as inhibitors of IFNγ function | |
| BR112017026713B1 (pt) | Proteínas de fusão de imunoglobulina, composição farmacêutica e método para produzir as mesmas |